Welcome to the e-CCO Library!
Y-ECCO Literature Review: Cyclosporine or infl iximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study
ECCO News Issue 01/2012
Dirk P. Van Asseldonk
Y-ECCO Literature Review: Early administration of azathioprine versus conventional management of Crohn’s Disease: A randomised controlled trial
ECCO News Issue 03/2013
Anja Schirbel
Y-ECCO Literature Review: Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
ECCO News Issue 04/2011
Johanne Brooks
Y-ECCO Literature Review: East-West gradient in the incidence of Inflammatory Bowel Disease in Europe: the ECCO-EpiCom inception cohort
ECCO News Issue 04/2013
Daniel Trabulo
Y-ECCO Literature Review: Etrolizumab as induction therapy for ulcerative colitis: A randomised, controlled, phase 2 trial
ECCO News Issue 03/2014
Triana Lobatón
Y-ECCO Literature Review: Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn’s Disease
ECCO News Issue 02/2015
Sandrine Coumes
Y-ECCO Literature Review: Flt3 ligand expands CD103+ dendritic cells and FoxP3+ T regulatory cells, and attenuates Crohn’s-like murine ileitis
ECCO News Issue 01/2012
Sander van der Marel
Y-ECCO Literature Review: Gene-microbiota interactions contribute to the pathogenesis of Inflammatory Bowel Disease
ECCO News Issue 03/2016
Floris Imhann
Y-ECCO Literature Review: Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells
ECCO News Issue 03/2015
Timon Adolph
Y-ECCO Literature Review: Identification of patients with variants in TPMT and dose reduction reduces hematologic events during thiopurine treatment of Inflammatory Bowel Disease
ECCO News Issue 04/2015
Vasile Balaban
Y-ECCO Literature Review: IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient.
ECCO News Issue 02/2011
Christine Breynaert
Y-ECCO Literature Review: Incidence and phenotype of Inflammatory Bowel Disease based on results From the Asia-Pacific Crohn’s and Colitis Epidemiology Study
ECCO News Issue 03/2013
Valérie Pittet
Y-ECCO Literature Review: Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn’s Disease
ECCO News Issue 02/2014
Anna Testa
Y-ECCO Literature Review: Individualised therapy is more costeffective than dose intensification in patients with Crohn’s Disease who lose response to anti-TNF treatment: A randomised, controlled trial
ECCO News Issue 03/2014
Katalin E. Müller
Y-ECCO Literature Review: Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum
ECCO News Issue 01/2011
Jan Wehkamp
Y-ECCO Literature Review: Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
ECCO News Issue 01/2011
James Lee
Y-ECCO Literature Review: Infliximab and complications after colectomy in patients with ulcerative colitis
ECCO News Issue 04/2011
Gianluca Pellino
Y-ECCO Literature Review: Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s Disease after ileocolonic resection
ECCO News Issue 02/2016
Paula Sousa
Y-ECCO Literature Review: Influence of ileal pouch anal anastomosis on bone loss in ulcerative colitis patients
ECCO News Issue 03/2011
Alexander Esser
Y-ECCO Literature Review: Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis
ECCO News Issue 04/2011
Colin de Haar